Alzheimer’s: A Turning Point?
Fergus Walsh follows patients with Alzheimer's disease who have been taking two new drugs that have been shown to slow down its progression. Is this a turning point in its treatment?
Around 900,000 people in the UK are living with dementia, and two-thirds of them have Alzheimer’s. For patients and their loved ones, it’s a devastating disease. But two new drugs have shown, for the first time, that the relentless progression of Alzheimer’s can be slowed down. With exclusive access to the UK trials, Fergus Walsh follows patients who have been on the drugs and asks if this is a turning point that could lead to the transformation of the treatment of the disease.
Last on
More episodes
Credits
| Role | Contributor |
|---|---|
| Reporter | Fergus Walsh |
| Editor | Karen Wightman |
| Executive Producer | Adam Grimley |
| Producer | Alison Priestley |
| Director | Alison Priestley |
Broadcasts
Featured in...
![]()
A Matter of Life and Health
Global breakthroughs, thought provoking experiments, and medical triumphs
Explore the wider challenges that people with a learning disability face in society, and how this impacts on their health
Find out more with The Open University.